Fighting cardiovascular disease with acne drug
(European Molecular Biology Laboratory) Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne. The study was published on 8 September in Cell Reports. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2020 Category: International Medicine & Public Health Source Type: news

14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban
The cardiac membrane protein phospholamban (PLN) is targeted by protein kinase A (PKA) at Ser16 and by Ca2+/calmodulin-dependent protein kinase II (CaMKII) at Thr17. β-Adrenergic stimulation and PKA-dependent phosphorylation of Ser16 acutely stimulate the sarcoplasmic reticulum calcium pump (SERCA) by relieving its inhibition by PLN. CaMKII-dependent phosphorylation may lead to longer-lasting SERCA stimulation and may sustain maladaptive Ca2+ handling. Here, we demonstrated that phosphorylation at either Ser16 or Thr17 converted PLN into a target for the phosphoadaptor protein 14-3-3 with different affinities. 14-3-3 ...
Source: Signal Transduction Knowledge Environment - September 1, 2020 Category: Science Authors: Menzel, J., Kownatzki-Danger, D., Tokar, S., Ballone, A., Unthan-Fechner, K., Kilisch, M., Lenz, C., Urlaub, H., Mori, M., Ottmann, C., Shattock, M. J., Lehnart, S. E., Schwappach, B. Tags: STKE Research Articles Source Type: news

Study finds asymptomatic Chagas patients are at a high risk for cardiac disease
(University of Colorado Anschutz Medical Campus) People living with Chagas disease without symptoms or signs of cardiac injury are at high risk of developing cardiomyopathy, a progressive heart disease, and the risk more than doubled among patients with acute infections, according to a new study from the University of Colorado School of Medicine at the Anschutz Medical Campus. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 31, 2020 Category: Infectious Diseases Source Type: news

Preparticipation CV Screening: Who Gets the Red Card? Preparticipation CV Screening: Who Gets the Red Card?
Which cardiac conditions are disqualifying for kids who play sports? From hypertrophic cardiomyopathy to heart transplant, Mayo Clinic's Jonathan Johnson and Bernard Gersh have answers that may surprise you.Mayo Clinic (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - August 12, 2020 Category: Orthopaedics Tags: Cardiology Commentary Source Type: news

What Are Common Fatty Acid Oxidation Metabolic Disorders?
Discussion All cells and particularly their mitochondria need an energy source. Glucose is one of the most common ones, but also fatty acids, lactate, pyruvate, ketones, and amino acids. Fatty acids are formed with a carboxylic acid with a long aliphatic carbon chain usually with even numbers of carbon atoms (usually 4-28 most commonly). Most are unbranched and in foods are usually found in the form of esters. Fatty acids are important energy sources for the heart (50-70%) but also skeletal muscle where resting muscle uses both glucose and fatty acids. During fasting or increased stress fatty acids become a major source o...
Source: PediatricEducation.org - July 27, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

UCalgary research study finds MRI effective in predicting major cardiac events
(University of Calgary) An international study led by Dr. James White, a clinician and researcher at the University of Calgary finds magnetic resonance imaging can be used to predict major cardiac events for people diagnosed dilated cardiomyopathy. White's study confirms about 40 per cent of patients with DCM have scarring patterns on their heart muscle which can be seen with MRI. These patterns are associated with higher risk of future heart failure admissions, life-threatening heart rhythms and death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2020 Category: International Medicine & Public Health Source Type: news

Can COVID-19 Promote Takotsubo Syndrome? Perhaps Not Directly Can COVID-19 Promote Takotsubo Syndrome? Perhaps Not Directly
The prevalence of stress cardiomyopathy, perhaps underappreciated as part of the pandemic's toll, seemed to turn sharply upward in patients presenting with ACS in March and April.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 13, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Incidence of Takotsubo Cardiomyopathy Up During COVID-19
FRIDAY, July 10, 2020 -- The incidence of Takotsubo cardiomyopathy has increased during the COVID-19 pandemic, according to a study published online July 9 in JAMA Network Open. Ahmad Jabri, M.D., from Cleveland Clinic Akron General, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 10, 2020 Category: Pharmaceuticals Source Type: news

' Broken Heart Syndrome' Has Risen During Pandemic: Study
THURSDAY, July 9, 2020 -- Doctors at one Ohio hospital system have discovered yet another possible consequence of the COVID-19 pandemic: More cases of " broken heart syndrome. " The condition -- which doctors call stress cardiomyopathy -- appears... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 9, 2020 Category: General Medicine Source Type: news

Comparing stress cardiomyopathy before, during COVID-19 pandemic
(JAMA Network) Patients with   acute coronary syndrome presenting during the COVID-19 pandemic were compared with patients presenting at times prior to the pandemic to investigate the incidence of stress cardiomyopathy during the pandemic in this observational study. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 9, 2020 Category: Infectious Diseases Source Type: news

Cardiomyopathy | Medscape Cardiomyopathy | Medscape
Review in-depth clinical information, latest medical news, and guidelines for management of various types of cardiomyopathy, including viral cardiomyopathy, infiltrative cardiomyopathy, postpartum cardiomyopathy, obstructive cardiomyopathy, primary cardiomyopathy, or idiopathic cardiomyopathy. Read articles about causes of cardiomyopathy symptoms and cardiomyopathy treatment. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 8, 2020 Category: Consumer Health News Tags: Resource Center Source Type: news

Fat cells found to play a central role in renal failure-associated cardiomyopathy
(Marshall University Joan C. Edwards School of Medicine) New research from a team at the Marshall University Joan C. Edwards School of Medicine reveals the central role of fat cells in the systemic oxidant stress observed in renal failure-associated cardiomyopathy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2020 Category: International Medicine & Public Health Source Type: news

Towbin receives National Institutes of Health research project grant
(Le Bonheur Children's Hospital) Jeffrey A. Towbin, MD, of Le Bonheur Children's Hospital and the University of Tennessee Health Science Center was awarded a Research Project Grant (R01) from the National Institutes of Health (NIH) with co-principal investigators Enkhsaikha Purevjav, MD, PhD and Lu Lu, MD, MS. He is lead principal investigator on the project 'Discovery of Modifier Genes in Cardiomyopathy..' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 26, 2020 Category: International Medicine & Public Health Source Type: news

Emergency in a Dilated Cardiomyopathy Patient Emergency in a Dilated Cardiomyopathy Patient
A 76-year-old woman with dilated cardiomyopathy has a rapid heart rate associated with hypotension. What does her ECG show?Medscape Cardiology (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 18, 2020 Category: Cardiology Tags: Cardiology Clinical Case Source Type: news

High-Dose Tafamidis Boosts Survival in Cardiomyopathy High-Dose Tafamidis Boosts Survival in Cardiomyopathy
Tafamidis provided a significantly greater survival benefit in patients with transthyretin amyloid cardiomyopathy in the long-term extension of the landmark ATTR-ACT trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 9, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Is Takotsubo Cardiomyopathy A Heart Attack
Is Takotsubo Cardiomyopathy a Heart Attack? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 9, 2020 Category: General Medicine Source Type: news

Hypertrophic Cardiomyopathy
What Is the Life Expectancy of Someone with Hypertrophic Cardiomyopathy? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 8, 2020 Category: General Medicine Source Type: news

PKCdelta causes sepsis-induced cardiomyopathy by inducing mitochondrial dysfunction
Sepsis-induced cardiomyopathy (SIC) is associated with increased patient mortality. At present, there are no specific therapies for SIC. Previous studies have reported increased reactive oxygen species (ROS) and mitochondrial dysfunction during SIC. However, a unifying mechanism remains to be defined. We hypothesized that PKCdelta is required for abnormal calcium handling and cardiac mitochondrial dysfunction during sepsis and that genetic deletion of PKCdelta would be protective. Polymicrobial sepsis induced by cecal ligation and puncture (CLP) surgery decreased the ejection fraction of wild-type (WT) mice but not PKCdelt...
Source: Current Awareness Service for Health (CASH) - June 4, 2020 Category: Consumer Health News Source Type: news

Diagnosis of Hypertrophic Cardiomyopathy: What Every Cardiologist Needs to Know Diagnosis of Hypertrophic Cardiomyopathy: What Every Cardiologist Needs to Know
Although it is the most common inherited monogenic cardiac disorder, affecting up to 0.5% of the population, there is a gap in the recognition of this condition.ACC.org (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 22, 2020 Category: Cardiology Tags: Cardiology Article Source Type: news

Functional Gains From Novel Agent for OHCM, Top-line Results Functional Gains From Novel Agent for OHCM, Top-line Results
Patients with obstructive hypertrophic cardiomyopathy showed consistent hemodynamic and functional gains on mavacamten, which targets cardiac myosin, in top-line results released by MyoKardia.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 12, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Peninsula heart drug maker soars on positive late-stage clinical trial
Aiming to ask regulators early next year to approve its treatment for a potentially fatal heart condition, a Peninsula company's stock jumped more than 70% today on news that its drug passed a critical late-stage clinical trial. MyoKardia Inc. (NASDAQ: MYOK) of Brisbane said early data from a 251-patient, Phase III clinical trial indicates that people with a heart condition known as symptomatic, obstructive hypertrophic cardiomyopathy, or HCM, who were given the drug mavacamten over 30 weeks saw… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 11, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Peninsula heart drug maker soars on positive late-stage clinical trial
Aiming to ask regulators early next year to approve its treatment for a potentially fatal heart condition, a Peninsula company's stock jumped more than 70% today on news that its drug passed a critical late-stage clinical trial. MyoKardia Inc. (NASDAQ: MYOK) of Brisbane said early data from a 251-patient, Phase III clinical trial indicates that people with a heart condition known as symptomatic, obstructive hypertrophic cardiomyopathy, or HCM, who were given the drug mavacamten over 30 weeks saw… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 11, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

Untangling the Physiology of Transthyretin Cardiac Amyloidosis Untangling the Physiology of Transthyretin Cardiac Amyloidosis
A new study investigates echocardiographic phenotypes of transthyretin cardiac amyloidosis, the most common etiology of restrictive cardiomyopathy, identifying parameters predictive of survival.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 11, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Connecting the dots between heart disease, potential for worse COVID-19 outcomes
(Mayo Clinic) People with certain heart diseases may be more susceptible to worse outcomes with COVID-19, but the reason why has remained unknown. New research from Mayo Clinic indicates that in patients with one specific type of heart disease ? obstructive hypertrophic cardiomyopathy (HCM) ? the heart increases production of the ACE2 RNA transcript and the translated ACE2 protein. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 27, 2020 Category: Infectious Diseases Source Type: news

Physicians, scientists and physician-scientists connect dots between heart disease, potential for worse COVID-19 outcomes
ROCHESTER, Minn. ? People with certain heart diseases may be more susceptible to worse outcomes with COVID-19, but the reason why has remained unknown. New research from Mayo Clinic indicates that in patients with one specific type of heart disease ? obstructive hypertrophic cardiomyopathy (HCM) ? the heart increases production of the ACE2 RNA transcript [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 27, 2020 Category: Databases & Libraries Source Type: news

DDT COA #000084: Kansas City Cardiomyopathy Questionnaire (KCCQ)
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 21, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Transplanted Hearts Quickly Show Signs of Disease in Diabetes Transplanted Hearts Quickly Show Signs of Disease in Diabetes
An'elegant'new study offers insights into the pathogenesis of diabetic cardiomyopathy and could provide a model for the study of other chronic heart diseases.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 23, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

What Causes Tachycardia?
Discussion Tachycardia is a rapid heart rate that is above normal for age and level of exertion. Tachycardia is common, particularly sinus tachycardia due to normally encountered circumstances such as pain, fever or exercise. It is usually a normal physiologic process but sustained tachycardia often indicates a potentially abnormal underlying cause. Sinus tachycardia has a rapid heart rate with normal P waves and P-R intervals and variations from moment to moment and respiration. Generally it is not over 200 beats/minute. Vagal stimulation can slow the heart rate; this is a gradual slowing, not an abrupt slowing seen in ...
Source: PediatricEducation.org - March 23, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Tafamidis not cost effective for transthyretin amyloid cardiomyopathy
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - March 1, 2020 Category: Drugs & Pharmacology Source Type: news

Image of the Day: Arrhythmogenic Cardiomyopathy
Scientists identify a potential biomarker for predicting the progression of a deadly cardiac disease. (Source: The Scientist)
Source: The Scientist - February 24, 2020 Category: Science Tags: Image of the Day Source Type: news

Mayo researchers create, test AI to improve EKG testing for hypertrophic cardiomyopathy
(Mayo Clinic) An approach based on artificial intelligence (AI) may allow EKGs to be used to screen for hypertrophic cardiomyopathy in the future. With hypertrophic cardiomyopathy, the heart walls become thick and may interfere with the heart's ability to function properly. The disease also predisposes some patients to potentially fatal abnormal rhythms. Current EKG technology has limited diagnostic yield for this disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 18, 2020 Category: International Medicine & Public Health Source Type: news

Jan 17 2019 This Week in Cardiology Jan 17 2019 This Week in Cardiology
EXCEL, amyloid cardiomyopathy, drug prices, palliative care in cardiology, and gender bias are the topics covered by Dr John Mandrola in this week ’ s podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 17, 2020 Category: Cardiology Tags: Cardiology Commentary Source Type: news

Medical News Today: Cardiomyopathy: What to know
Cardiomyopathy is a disease that involves a weakened heart muscle. The condition makes it difficult for the heart to pump blood throughout the body. Read more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 10, 2020 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Jan 10 2020 This Week in Cardiology Jan 10 2020 This Week in Cardiology
The Excel trial, peripartum cardiomyopathy, marathoning, hot-spotting, and leadership in innovation are the topics discussed by Dr. John Mandrola in this week ’ s podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 10, 2020 Category: Cardiology Tags: Cardiology Commentary Source Type: news

The Unholy Pairing of Cancer and Peripartum Cardiomyopathy The Unholy Pairing of Cancer and Peripartum Cardiomyopathy
New findings support the theory that peripartum cardiomyopathy (PPCM) may promote cancer, and also that a history of cancer may raise the risk for PPCM.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 7, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Underlying Cardiomyopathy May Cause Some Cryptogenic Stroke Underlying Cardiomyopathy May Cause Some Cryptogenic Stroke
A new study used cardiac MRI to detect cardiomyopathies in patients with an ischemic stroke of unknown origin.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 2, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Girl, 12, saved by miracle heart transplant after nearly dying from a rare disease
Kayleigh Llewellyn, of County Durham, was diagnosed with cardiomyopathy three months ago. She was put on the urgent transplant list and a donor organ was found before Christmas. (Source: the Mail online | Health)
Source: the Mail online | Health - December 31, 2019 Category: Consumer Health News Source Type: news

Pregnancy - Related Heart Failure Tied to Higher Cancer Risk
Ninefold higher cancer occurrence seen both before and after peripartum cardiomyopathy diagnosis (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 18, 2019 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Gynecology, Oncology, Pathology, Journal, Source Type: news

Pregnancy-Related Heart Failure Tied to Higher Cancer Risk
WEDNESDAY, Dec. 18, 2019 -- Patients with peripartum cardiomyopathy (PPCM) are more likely to have cancer before PPCM diagnosis and more likely to develop cancer after PPCM, according to a study published in the December issue of the JACC:... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 18, 2019 Category: Pharmaceuticals Source Type: news

Pfizer's rare disease drug gets EMA's positive recommendation
Pfizer Inc said on Friday the European Medicines Agency granted the company a positive recommendation for approval of its treatment for a rare disorder that occurs in patients with cardiomyopathy. (Source: Reuters: Health)
Source: Reuters: Health - December 13, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

AI-Enabled Stethoscope Brings Specialized Knowledge to the Point of Care
Recent results of a collaborative study between Eko and the Mayo Clinic demonstrating the use of Eko’s DUO digital stethoscope as a heart failure screening tool suggest that the device could help identify asymptomatic patients with low ejection fraction during routine physical examinations. “The low ejection fraction algorithm was used with a very specific protocol of four touchpoints—three on the chest and one on the fingers,” said Steve Pham, MD, vice president of clinical and research affairs at Eko, in an interview with MD+DI. â&#...
Source: MDDI - December 11, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Digital Health Source Type: news

Racial Differences Seen With Hypertrophic Cardiomyopathy
THURSDAY, Dec. 5, 2019 -- Racial differences in disease expression and adverse clinical outcomes exist between black and white patients with hypertrophic cardiomyopathy, according to a study published online Dec. 4 in JAMA Cardiology. Lauren A.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2019 Category: Pharmaceuticals Source Type: news

Sepsis induced cardiomyopathy: Pathophysiology and use of mechanical circulatory support for refractory shock
Sepsis remains a major cause of morbidity and mortality, and sepsis-induced cardiomyopathy (SCM) has been recognized as a relevant complication. In this article, the pathophysiology of SCM and the literature regarding the clinical care with a focus on the use of mechanical circulatory support for the rescue of patients with severe SCM are reviewed. Lastly, a pragmatic approach to the care of this complex patient population is provided using a representative case example. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 28, 2019 Category: Consumer Health News Source Type: news

Researchers discover new mutations in gene associated with disease that causes the heart to weaken
(Intermountain Medical Center) Researchers from the Intermountain Healthcare Heart Institute in Salt Lake City have identified new mutations in a gene commonly associated with non-ischemic dilated cardiomyopathy (NIDC), a disease that weakens the heart muscle, making it more difficult to adequately circulate blood to meet the body's needs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 17, 2019 Category: International Medicine & Public Health Source Type: news

Early diagnosis of pregnancy-associated heart disease linked to better outcomes
(University of Pennsylvania School of Medicine) Women who are diagnosed with peripartum cardiomyopathy (PPCM) during late pregnancy or within a month following delivery are more likely to experience restored cardiac function and improved outcomes compared to those who are diagnosed later in the postpartum period, according to a new study. The findings underscore the need for increased awareness and monitoring of heart failure symptoms, particularly among black women, who, on average, are diagnosed significantly later than white patients, researchers found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 16, 2019 Category: International Medicine & Public Health Source Type: news

Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
Myocarditis can develop into inflammatory cardiomyopathy through chronic stimulation of myosin heavy chain 6–specific T helper (TH)1 and TH17 cells. However, mechanisms governing the cardiotoxicity programming of heart-specific T cells have remained elusive. Using a mouse model of spontaneous autoimmune myocarditis, we show that progression of myocarditis to lethal heart disease depends on cardiac myosin–specific TH17 cells imprinted in the intestine by a commensal Bacteroides species peptide mimic. Both the successful prevention of lethal disease in mice by antibiotic therapy and the significantly elevated Bac...
Source: ScienceNOW - November 14, 2019 Category: Science Authors: Gil-Cruz, C., Perez-Shibayama, C., De Martin, A., Ronchi, F., van der Borght, K., Niederer, R., Onder, L., Lütge, M., Novkovic, M., Nindl, V., Ramos, G., Arnoldini, M., Slack, E. M. C., Boivin-Jahns, V., Jahns, R., Wyss, M., Mooser, C., Lambrecht, Tags: Immunology, Medicine, Diseases reports Source Type: news

Ghana: Diabetic Cardiomyopathy - A Look At Options
[Ghanaian Times] I have devoted the last few days to sharing information on diabetes. The feedbacks have been good. There was one that I would like to share with you, dear reader.Can diabetes on its own cause heart disease in a person? The response is yes. There is actually a condition known as diabetic cardiomyopathy. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 13, 2019 Category: African Health Source Type: news

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
(Massachusetts General Hospital) Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2019 Category: Cancer & Oncology Source Type: news

Peripartum Cardiomyopathy Recovery in Blacks Better in Canada? Peripartum Cardiomyopathy Recovery in Blacks Better in Canada?
In a small Canadian cohort, LVEF recovery after peripartum cardiomyopathy was similar for black women and white women, whereas in a US cohort, black women fared worse, as has been seen before.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

World's most comprehensive study of a deadly heart condition yields 1st results
(University of Virginia Health System) Researchers have revealed the initial results from the world's largest comprehensive study of hypertrophic cardiomyopathy, an abnormal thickening of the heart that often goes undiagnosed and can prove deadly. The condition can present at any age, and it is the most common cause of sudden cardiac death in young athletes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 7, 2019 Category: International Medicine & Public Health Source Type: news